Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whorwell

Showing results (201-210 of 249) with videos related to

Pageof 25
Sort By:
Tissue Antigens|November 7, 1999
Interleukin-10 (IL-10) genotypes in inflammatory bowel diseaseA Tagore, W M Gonsalkorale, V Pravica, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2008
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipationA Agrawal, L A Houghton, J Morris, et al.
Gut|May 10, 2007
Guidelines on the irritable bowel syndrome: mechanisms and practical managementR Spiller, Q Aziz, F Creed, et al.
Therapeutic Advances in Gastroenterology|July 24, 2018
The short-term effects of posterior tibial nerve stimulation on anorectal physiology in patients with faecal incontinence: a single centre experienceNick A Heywood, James S Pearson, James E Nicholson, et al.
British Heart Journal|September 1, 1987
Left ventricular function and oesophageal function in patients with angina pectoris and normal coronary angiogramsP M Schofield, N H Brooks, S Colgan, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Abnormalities of mucosal serotonin metabolism and 5-HT<sub>3</sub> receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetronDavid Gunn, Klara Garsed, Ching Lam, et al.
Clinical Therapeutics|June 6, 2006
Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteersLesley A Houghton, Wendy Atkinson, Peter J Whorwell, et al.
Gut|June 27, 2022
Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)Carol Angela Howell, Anu Kemppinen, Victoria Allgar, et al.
Trials|February 1, 2020
Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adultsAnu Kemppinen, Carol Howell, Victoria Allgar, et al.
BMC Gastroenterology|December 22, 2011
A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)Carla E Flik, Yanda R van Rood, Wijnand Laan, et al.
Pageof 25

Showing results (201-210 of 249) with videos related to

Sort By:
Pageof 25
Tissue Antigens|November 7, 1999
Interleukin-10 (IL-10) genotypes in inflammatory bowel diseaseA Tagore, W M Gonsalkorale, V Pravica, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2008
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipationA Agrawal, L A Houghton, J Morris, et al.
Gut|May 10, 2007
Guidelines on the irritable bowel syndrome: mechanisms and practical managementR Spiller, Q Aziz, F Creed, et al.
Therapeutic Advances in Gastroenterology|July 24, 2018
The short-term effects of posterior tibial nerve stimulation on anorectal physiology in patients with faecal incontinence: a single centre experienceNick A Heywood, James S Pearson, James E Nicholson, et al.
British Heart Journal|September 1, 1987
Left ventricular function and oesophageal function in patients with angina pectoris and normal coronary angiogramsP M Schofield, N H Brooks, S Colgan, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Abnormalities of mucosal serotonin metabolism and 5-HT<sub>3</sub> receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetronDavid Gunn, Klara Garsed, Ching Lam, et al.
Clinical Therapeutics|June 6, 2006
Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteersLesley A Houghton, Wendy Atkinson, Peter J Whorwell, et al.
Gut|June 27, 2022
Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)Carol Angela Howell, Anu Kemppinen, Victoria Allgar, et al.
Trials|February 1, 2020
Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adultsAnu Kemppinen, Carol Howell, Victoria Allgar, et al.
BMC Gastroenterology|December 22, 2011
A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)Carla E Flik, Yanda R van Rood, Wijnand Laan, et al.
Pageof 25